|
|
|
|
|
The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests |
2559 |
# |
|
|
|
|
|
The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients |
2559 |
# |
|
|
|
|
|
The clinical relevance of oliguria in the critically ill patient: Analysis of a large observational database |
2563 |
# |
|
|
|
|
|
The Clinical Outcomes of Different eGFR Strata and Time in Therapeutic Range in Atrial Fibrillation Patients with Chronic Kidney Disease: A Nationwide Cohort Study |
2564 |
# |
|
|
|
|
|
The clinical outcome of acute kidney injury in critically ill Thai patients stratified with RIFLE classification. |
2552 |
# |
|
|
|
|
|
The clinical impact of the COVID-19 pandemic on gastroenterology practices within Southeast Asia |
2564 |
# |
|
|
|
|
|
The Clinical Impact of [68Ga]-DOTATATE PET/CT for the Diagnosis and Management of Ectopic Adrenocorticotropic Hormone – Secreting Tumours |
2562 |
# |
|
|
|
|
|
The clinical features, risk of prolonged hospitalization and household infections of hospitalized children for pandemic 2009 influenza A (H1N1) virus infection in Thailand |
2555 |
# |
|
|
|
|
|
The clavicular fracture: a biomechanical study of the mechanism of clavicular fracture and modes of the fracture. |
2543 |
# |
|
|
|
|
|
The Characteristics of Spinal Imaging in Thai Patients with Demyelinating Diseases |
2560 |
# |
|
|
|
|
|
The characteristics of spinal imaging in different types of demyelinating diseases. |
2559 |
# |
|
|
|
|
|
The characteristics and clinical outcome of metastatic NSCLC harboring uncommon EGFR mutation at Thailand's tertiary referral center |
2562 |
# |
|
|
|
|
|
The Changing Landscape of Alcohol Use and Alcohol Use Disorder During the COVID-19 Pandemic-Perspectives of Early Career Professionals in 16 Countries |
2563 |
# |
|
|
|
|
|
The cellular plasticity of human adipocytes |
2548 |
# |
|
|
|
|
|
The Case for Adopting the "Species Complex" Nomenclature for the Etiologic Agents of Cryptococcosis |
2560 |
# |
|
|
|
|
|
The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: Analysis protocol and baseline characteristic |
2552 |
# |
|
|
|
|
|
The Canadian Neurological Scale and the NIHSS: Development and Validation of a Simple Conversion Model |
2553 |
# |
|
|
|
|
|
The Calcaneal Crescent in Patients With and Without Plantar Fasciitis: An Ankle MRI Study |
2561 |
# |
|
|
|
|
|
The Burkholderia pseudomallei RpoE (AlgU) operon is involved in environmental stress tolerance and biofilm formation. |
2548 |
# |
|
|
|
|
|
THE BURDEN OF INVASIVE NEONATAL GROUP B STREPTOCOCCAL (GBS) DISEASE IN THAILAND AND THE PHILIPPINES |
2558 |
# |
|
|
|
|
|
The burden of HIV-associated neurocognitive disorder (HAND) in the Asia-Pacific region and recommendations for screening. |
2558 |
# |
|
|
|
|
|
The burden of HIV-associated neurocognitive disorder (HAND) in the Asia-Pacific region and recommendations for screening |
2559 |
# |
|
|
|
|
|
The BRCA1 3 '-UTR: 5711+421T/T_5711+1286T/T Genotype Is a Possible Breast and Ovarian Cancer Risk Factor |
2552 |
# |
|
|
|
|
|
The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation |
2560 |
# |
|
|
|
|
|
The Blomia tropicalis allergen Blo t 7 stimulates innate immune signalling pathways through TLR2 |
2561 |
# |
|
|
|
|
|
The Bleeding Time: Review of Basic Principle, Clinical Applications, and Laboratory Pitfalls |
2556 |
# |
|
|
|
|
|
The Berlin Declaration: Inspiration for primary care. |
2560 |
# |
|
|
|
|
|
The benefits of early intervention using lenalidomide for high-risk smoldering multiple myeloma: emerging data and its promising clinical impact |
2564 |
# |
|
|
|
|
|
The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study. |
2559 |
# |
|
|
|
|
|
The Believe Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept in Adult Beta-Thalassemia Patients Who Require Regular Red Blood Cell (RBC) Transfusions |
2562 |
# |